Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Peptron

1997 FOUNDED
PUBLIC STATUS
61-70 EMPLOYEES
087010 STOCK SYMBOL
$21.13 SHARE PRICE (As of Friday Closing)
Description

Manufacturer of pharmaceutical drugs. The company manufactures and distributes pharmaceutical medicine for the treatment of prostate cancer, diabetes, neurodegenerative disorders and other ailments in South Korea and other countries.

Website
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Other Pharmaceuticals and Biotechnology
Other Industries
Biotechnology
Drug Discovery
Stock Exchange
KRX
Primary Office
  • 37-24, Yuseong-daero, 1628 beon-gil
  • Daejeon, Yuseong-gu 305-811
  • South Korea

+82 000-000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Peptron’s full profile, request a free trial.

Peptron Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$18.66 - $38.71 $308M $20.11 -$0.30 126K 15.3M

Peptron Financials Summary

In Thousands,
USD
TTM
31-Mar-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
FY 2015
31-Dec-2015
Enterprise Value 448,363 434,967 164,833 325,980
Revenue 3,517 2,836 2,687 2,488
EBITDA (3,870) (3,873) (2,427) (1,882)
Net Income (4,275) (3,904) (2,739) (2,415)
Total Assets 73,177 49,643 47,914 18,373
Total Debt 18,431 1,872 1,655 1,866
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Peptron Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Peptron‘s full profile, request access.

Request full access to PitchBook